TTUHSC SOM Peer Tutoring Forum
 


  << Previous Topic | Next Topic >>Return to Index  

More corrections for the pharm grouped questions

December 8 2001 at 10:58 PM
  (Login catdograccoon)

 
In the antiepileptics section:
#6 The key says (c). However, the notes and scribe both say that all of these drugs can be used for partial seizures (there isn't an answer option for this).
In the Antopsychotics section:
#16 The key says 'B', for which the inverse statement would be true. I'm voting for 'D' ie that an advantage of haloperidol over clozapine for treatment of psychosis is that haloperidol has less risk of agranulocytosis
OK, enjoy the rest of your studying (not!) -- Maggie

 
 Respond to this message   
AuthorReply

(Login mburton2)
Forum Owner

Lippincott

December 8 2001, 11:14 PM 

I don't know about the notes and scribe (haven't read 'em), but Lippincott says Valproic acid isn't used for partial seizures. Look at the chart on page 145 or the discussion at the bottom of 148.

 
 Respond to this message   

(Login mburton2)
Forum Owner

Regarding antipsychotic

December 8 2001, 11:37 PM 

I think you're right about Antipsychotic #16. You wouldn't use haloperidol over clozapine b/c of less interference with levodopa (B). Haloperidol is contraindicated in parkinson's, causing extrapyramidal effects itself (Lipp 84, 130). But clozapine does cause agranulocytosis, so D seems like the better choice.

 
 Respond to this message   
eringoddess
(no login)

Anti-epileptics and anti-psychotics

December 9 2001, 1:12 AM 

Thanks, Maggie. As far as #6 for anti-epileptics, the question was from 1994 so I think it's just outdated. So there's no good answer but Valproic acid I guess isn't a first-line drug.

Also, in anti-epileptics, #15 should be C.

In anti-psychotics, #16 should definitely be D.

 
 Respond to this message   
Current Topic - More corrections for the pharm grouped questions
  << Previous Topic | Next Topic >>Return to Index  
Create your own forum at Network54
 Copyright © 1999-2009 Network54. All rights reserved.   Terms of Use   Privacy Statement